Drug Shortage Report for TARO-CIPROFLOX
| Report ID | 183077 |
| Drug Identification Number | 02303728 |
| Brand name | TARO-CIPROFLOX |
| Common or Proper name | CIPROFLOX |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 250MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-01 |
| Estimated end date | 2024-03-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.